Clinical Trials
27 trialsScreening for Hematology Branch Protocols
National Institutes of Health Clinical Center (CC)
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
National Institutes of Health Clinical Center (CC)
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
Early Intervention in High Risk CCUS
Dana-Farber Cancer Institute
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Mayo Clinic
MDS
National Heart, Lung, and Blood Institute (NHLBI)
A Study of Emapalumab for Pediatric Aplastic Anemia
Memorial Sloan Kettering Cancer Center
RAFA
Children's Hospital Medical Center, Cincinnati
HAPLOTAB
Baylor College of Medicine
BMS-986253 in Myelodysplastic Syndromes
National Institutes of Health Clinical Center (CC)
HemEx
Rigshospitalet, Denmark
Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Rigshospitalet, Denmark
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Instituto de Investigación Biomédica de Salamanca
EVITA
Rigshospitalet, Denmark
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Bellicum Pharmaceuticals
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
SS1
Baylor College of Medicine
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
University of California, San Francisco
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
Traws Pharma, Inc.
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
Masonic Cancer Center, University of Minnesota
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
Tarix Pharmaceuticals
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
Traws Pharma, Inc.
PEMVITASTART
Post Graduate Institute of Medical Education and Research, Chandigarh
Low Bacterial Diet in Patients With Cytopenia
Maastricht University Medical Center
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
H. Lee Moffitt Cancer Center and Research Institute
Progression of Hematopoietic Diseases in Shanghai, China
University of Colorado, Denver